from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1406/fmt

LFCtreatmentdescriptionclass of inhibitor

0.000

Amikacinug/mL Amikacintranslation

0.000

Cap5-10ug/mL Capreomycintranslation

0.000

Rox10-50 ug/mL Roxithromycintranslation

0.000

SM2-5 ug/mL Streptomycintranslation

0.000

Tet5-10 ug/mL Tetracyclinetranslation

-0.368

Rif0.2-5ug/mL Rifampicintranscription

0.000

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.672

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.002

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.492

CPZ10-50 ug/mL Chlorpromazinerespiration

0.441

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.343

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

2.177

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.223

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.608

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.099

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.706

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.688

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.536

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.023

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

2.317

KCN5-20 ug/mL Potassium cyaniderespiration

-0.615

NaN30.2-2 mM Sodium aziderespiration

-0.357

Nigericin50 uM Nigericinrespiration

0.383

TRC10-150 ug/mL Triclosanrespiration

-0.414

TRZ10-25 ug/mL Thioridazinerespiration

0.943

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.321

menadione6-10 ug/mL Menadionerespiration

0.000

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.000

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.000

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.900

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.234

NRP_1Non-replicating persistence stage 1dosRassociated

0.000

Amp0.2mg/mL AmpicillincellWall

-0.195

Cephalexin20-100 ug/mL CephalexincellWall

0.536

Cerulenin0.32-5 ug/mL CerulenincellWall

0.086

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.716

EMB10-20 ug/mL EthambutolcellWall

0.000

Eta12-40 ug/mL EthionamidecellWall

0.000

INH0.2-0.4 ug/mL IsoniazidcellWall

0.000

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.945

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.974

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.031

BZA0.12 mg/mL BenzamidearomaticAmides

-0.554

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.077

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.319

H2O24 mM hydrogen peroxideDNAdamaging

0.000

Levo10 ug/mL LevofloxacinDNAdamaging

-0.004

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.602

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.000

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.979

UVUV-irradiationDNAdamaging

0.639

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.238

Antimycin12.5-50 ug/mL Antimycin A?

-0.219

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.558

PA_110-50 ug/mL Antitubercular compound PA-1?

0.356

PA_2110-50 ug/mL Antitubercular compound PA-21?

2.321

PA8240.2-2 ug/mL PA-824?

1.053

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.219

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.416

Verapamil50 uM Verapamil?

-0.711

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.752

methoxatin10-20 ug/mL Methoxatin?